Additionally, ALKBH2 has been shown to play an efficient role in pediatric brain tumors during chemotherapy treatment, and the combination of an ALKBH2 knockdown and cisplatin chemotherapy seems to improve the efficacy of treatment (Cetica et al. 2009; Wu et al. 2011b). Here, ALKBH2 is linked to brain neoplasm.